Quasispecies theory and the behavior of RNA viruses

PLoS Pathogens

Volumn 6, Issue 7, 2010, Pages 1-8

  Lauring, Adam S ^a   Andino, Raul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL NEURAL NETWORK; GENETIC VARIABILITY; MATHEMATICAL ANALYSIS; NONHUMAN; PREDICTION; QUASISPECIES THEORY; REVIEW; RNA VIRUS; VIRION; VIRUS ATTENUATION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS VIRULENCE; BIOLOGICAL MODEL; EVOLUTION; GENETICS; PHYSIOLOGY;

HEPATITIS C VIRUS; RNA VIRUSES;

BIOLOGICAL EVOLUTION; GENETIC VARIATION; MODELS, GENETIC; RNA VIRUSES;

EID: 77957658175     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001005     Document Type: Review

References (83)

1. Domingo E, Baranowski E, Ruiz-Jarabo CM, Martin-Hernandez AM, Saiz JC, et al. (1998) Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 4: 521-527.
2. Domingo E, Martin V, Perales C, Grande-Perez A, Garcia-Arriaza J, et al. (2006) Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 299: 51-82.
3. Duffy S, Shackelton LA, Holmes EC (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276.
4. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353: 1374-1385.
5. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
6. Rambaut A, Posada D, Crandall KA, Holmes EC (2004) The causes and consequences of HIV evolution. Nat Rev Genet 5: 52-61.
7. Fields BN, Knipe DM, Howley PM (2007) Fields virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2 v. (xix, 3091, I-3086 p.).
8. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110-121.
9. Gerrish PJ, Garcia-Lerma JG (2003) Mutation rate and the efficacy of antimicrobial drug treatment. Lancet Infect Dis 3: 28-32.
10. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, et al. (1982) Rapid evolution of RNA genomes. Science 215: 1577-1585.
11. Eigen M (1971) Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften 58: 465-523.
12. Biebricher CK, Eigen M (2006) What is a quasispecies? Curr Top Microbiol Immunol 299: 1-31.
13. Eigen M (1993) Viral quasispecies. Sci Am 269: 42-49.
14. Domingo E, Sabo D, Taniguchi T, Weissmann C (1978) Nucleotide sequence heterogeneity of an RNA phage population. Cell 13: 735-744.
15. Batschelet E, Domingo E, Weissmann C (1976) The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene 1: 27-32.
16. Steinhauer DA, Holland JJ (1987) Rapid evolution of RNA viruses. Annu Rev Microbiol 41: 409-433.
17. Vignuzzi M, Stone JK, Andino R (2005) Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res 107: 173-181.
18. Wilke CO (2005) Quasispecies theory in the context of population genetics. BMC Evol Biol 5: 44.
19. Orr HA (2009) Fitness and its role in evolutionary genetics. Nat Rev Genet 10: 531-539.
20. Quinones-Mateu ME, Arts EJ (2006) Virus fitness: concept, quantification, and application to HIV population dynamics. Curr Top Microbiol Immunol 299: 83-140.
21. Domingo E, Holland JJ (1997) RNA virus mutations and fitness for survival. Annu Rev Microbiol 51: 151-178.
22. de la Torre JC, Holland JJ (1990) RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol 64: 6278-6281.
23. Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC (2006) Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311: 236-238.
24. Wilke CO, Wang JL, Ofria C, Lenski RE, Adami C (2001) Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature 412: 331-333.
25. Burch CL, Chao L (2000) Evolvability of an RNA virus is determined by its mutational neighbourhood. Nature 406: 625-628.
26. Codoñer FM, Darós J-A, Solé RV, Elena SF (2006) The fittest versus the flattest: experimental confirmation of the quasispecies effect with subviral pathogens. PLoS Pathog 2: e136. doi:10.1371/journal.ppat.0020136.
27. Sanjuan R, Cuevas JM, Furio V, Holmes EC, Moya A (2007) Selection for Robustness in Mutagenized RNA Viruses. PLoS Genet 3: e93. doi:10.1371/journal.pgen.0030093.
28. Quer J, Hershey CL, Domingo E, Holland JJ, Novella IS (2001) Contingent neutrality in competing viral populations. J Virol 75: 7315-7320.
29. Draghi JA, Parsons TL, Wagner GP, Plotkin JB (2010) Mutational robustness can facilitate adaptation. Nature 463: 353-355.
30. Ariën KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, et al. (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19: 1555-1564.
31. Richman DD (2006) Antiviral drug resistance. Antiviral Res 71: 117-121.
32. Rolland M, Brander C, Nickle DC, Herbeck JT, Gottlieb GS, et al. (2007) HIV- 1 over time: fitness loss or robustness gain? Nat Rev Microbiol 5: 1-2.
33. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898-1903.
34. Overbaugh J, Bangham CR (2001) Selection forces and constraints on retroviral sequence variation. Science 292: 1106-1109.
35. Sanjuán R, Moya A, Elena SF (2004) The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci USA 101: 8396-8401.
36. Elena SF, Sanjuán R (2005) Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol 79: 11555-11558.
37. Holmes EC (2003) Error thresholds and the constraints to RNA virus evolution. Trends Microbiol 11: 543-546.
38. Biebricher CK, Eigen M (2005) The error threshold. Virus Res 107: 117-127.
39. Eigen M (2002) Error catastrophe and antiviral strategy. Proc Natl Acad Sci USA 99: 13374-13376.
40. Holland JJ, Domingo E, de la Torre JC, Steinhauer DA (1990) Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 64: 3960-3962.
41. Lee CH, Gilbertson DL, Novella IS, Huerta R, Domingo E, et al. (1997) Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol 71: 3636-3640.
42. Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98: 6895-6900.
43. Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY, et al. (2000) The broadspectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6: 1375-1379.
44. Domingo E, Pariente N, Airaksinen A, Gonzaĺez-Lopez C, Sierra S, et al. (2005) Foot-and-mouth disease virus evolution: exploring pathways towards virus extinction. Curr Top Microbiol Immunol 288: 149-173.
45. Grande-Perez A, Gomez-Mariano G, Lowenstein PR, Domingo E (2005) Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol 79: 10451-10459.
46. Grande-Perez A, Lazaro E, Lowenstein P, Domingo E, Manrubia SC (2005) Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102: 4448-4452.
47. Grande-Perez A, Sierra S, Castro MG, Domingo E, Lowenstein PR (2002) Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A 99: 12938-12943.
48. Sierra S, Dávila M, Lowenstein PR, Domingo E (2000) Response of foot-andmouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74: 8316-8323.
49. Malim MH (2009) APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond, B, Biol Sci 364: 675-687.
50. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
51. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
52. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
53. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98.
54. Vartanian JP, Meyerhans A, Sala M, Wain-Hobson S (1994) GRA hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci U S A 91: 3092-3096.
55. Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, et al. (2005) GRA hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol 79: 1975-1980.
56. Janini M, Rogers M, Birx DR, McCutchan FE (2001) Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol 75: 7973-7986.
57. Holmes RK, Malim MH, Bishop KN (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32: 118-128.
58. Anderson JP, Daifuku R, Loeb LA (2004) Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58: 183-205.
59. Severson WE, Schmaljohn CS, Javadian A, Jonsson CB (2003) Ribavirin causes error catastrophe during Hantaan virus replication. J Virol 77: 481-488.
60. Hofmann WP, Herrmann E, Sarrazin C, Zeuzem S (2008) Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms. Liver Int 28: 1332-1343.
61. Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308: 37-47.
62. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, et al. (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314: 20-26.
63. Loeb LA, Essigmann JM, Kazazi F, Zhang J, Rose KD, et al. (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci USA 96: 1492-1497.
64. Loeb LA, Mullins JI (2000) Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res Hum Retroviruses 16: 1-3.
65. Harris KS, Brabant W, Styrchak S, Gall A, Daifuku R (2005) KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral Res 67: 1-9.
66. Gonzalez-Lopez C, Arias A, Pariente N, Gomez-Mariano G, Domingo E (2004) Preextinction viral RNA can interfere with infectivity. J Virol 78: 3319-3324.
67. Springman R, Keller T, Molineux I, Bull J (2009) Evolution at a High Imposed Mutation Rate: Adaptation Obscures the Load in Phage T7. Genetics.
68. Gifford RJ, Rhee S-Y, Eriksson N, Liu TF, Kiuchi M, et al. (2008) Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS 22: 717-725.
69. Pillai SK, Wong JK, Barbour JD (2008) Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology 5: 26.
70. Mulder LCF, Harari A, Simon V (2008) Cytidine deamination induced HIV-1 drug resistance. Proc Natl Acad Sci USA 105: 5501-5506.
71. Pariente N, Sierra S, Airaksinen A (2005) Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Res 107: 183-193.
72. Pariente N, Airaksinen A, Domingo E (2003) Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J Virol 77: 7131-7138.
73. Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE (2005) Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem 280: 25706-25716.
74. Pfeiffer JK, Kirkegaard K (2003) A single mutation in poliovirus RNAdependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A 100: 7289-7294.
75. Pfeiffer JK, Kirkegaard K (2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1: e11. doi:10.1371/journal.ppat.0010011.
76. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439: 344-348.
77. Vignuzzi M, Wendt E, Andino R (2008) Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14: 154-161.
78. Racaniello VR (2006) One hundred years of poliovirus pathogenesis. Virology 344: 9-16.
79. Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR (1990) Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63: 353-362.
80. Bushman FD, Hoffmann C, Ronen K, Malani N, Minkah N, et al. (2008) Massively parallel pyrosequencing in HIV research. Aids 22: 1411-1415.
81. Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, et al. (2008) Viral population estimation using pyrosequencing. PLoS Comput Biol 4: e1000074. doi:10.1371/journal.pcbi.1000074.
82. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, et al. (2009) Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 199: 1275-1285.
83. Mazurkiewicz P, Tang CM, Boone C, Holden DW (2006) Signature-tagged mutagenesis: barcoding mutants for genome-wide screens. Nat Rev Genet 7: 929-939.